2025-22329: National Institute on Drug Abuse; Notice of Closed Meeting

Get alerted when the next rule lands

New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

Create a free account & build one →

What this rule does

2025-22329 — National Institute on Drug Abuse; Notice of Closed Meeting. Notice.

Plain-language description generated by AI — not the agency’s official summary, which we have not captured for this rule. Read the official text →

The rule, in full

314 words as published, December 09, 2025. View the original →

Federal Register, Volume 90 Issue 234 (Tuesday, December 9, 2025) [Federal Register Volume 90, Number 234 (Tuesday, December 9, 2025)] [Notices] [Page 57083] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2025-22329] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIDA. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute on Drug Abuse, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIDA. Date: January 21, 2026. Time: 9:15 a.m. to 4:05 p.m. Date: January 22, 2026. Time: 9:30 a.m. to 3:30 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Institute on Drug Abuse, NIH Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224. Meeting Format: Virtual Meeting. Contact Person: Megan E. Bollinger, M.S., Management Analyst, Office of the Scientific Director, National Institute on Drug Abuse, 251 Bayview Boulevard, Suite 200, Baltimore, MD 21224, (443) 740- 2466, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Zieta Charles, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025-22329 Filed 12-8-25; 8:45 am] BILLING CODE 4140-01-P

Don't miss the comment window

One Click Politics alerts you on every deadline, hearing, and rule change.

See all rules with comments due soon →